Zobrazeno 1 - 10
of 9 420
pro vyhledávání: '"Douillard JY"'
Autor:
Karapetis CS; Flinders Medical Centre, Adelaide, SA, Australia. c.karapetis@flinders.edu.au.; Flinders University, Adelaide, SA, Australia. c.karapetis@flinders.edu.au., Liu H; Mayo Clinic, Rochester, NY, USA., Sorich MJ; Flinders University, Adelaide, SA, Australia., Pederson LD; Mayo Clinic, Rochester, NY, USA., Van Cutsem E; University Hospitals Gasthuisberg Leuven and University of Leuven, Leuven, Belgium., Maughan T; University of Liverpool, Liverpool, UK., Douillard JY; University of Nantes and Integrated Centers of Oncology ICO Rene Gauducheau Cancer Nantes, Nantes, France., O'Callaghan CJ; Canadian Cancer Trials Group, Kingston, ON, Canada., Jonker D; The Ottawa Hospital Research Institute, Ottawa, ON, Canada., Bokemeyer C; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Sobrero A; Ospedale San Martino, Genova, Italy., Cremolini C; University of Pisa, Pisa, Italy., Chibaudel B; Franco-British Institute Levallois-Perre, Levallois-Perre, France., Zalcberg J; Dept of Medical Oncology, Alfred Health and School of Public Health, Monash University, Melbourne, VIC, Australia., Adams R; Velindre Cancer Centre Cardiff University, Cardiff, UK., Buyse M; International Drug Development Institute, Louvain-la-Neuve, Belgium., Peeters M; Antwerp University and Antwerp University Hospital, Antwerp, Belgium., Yoshino T; National Cancer Centre Hospital East, Kashiwa, Japan., de Gramont A; Franco-British Institute Levallois-Perre, Levallois-Perre, France., Shi Q; Mayo Clinic, Rochester, NY, USA.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 May; Vol. 130 (8), pp. 1269-1278. Date of Electronic Publication: 2024 Feb 24.
Autor:
Cohen R; Sorbonne University, Department of Medical Oncology, Hôpital Saint-Antoine, AP-HP, and INSERM UMRS 938, Équipe Instabilité des Microsatellites et Cancer, Équipe Labellisée par la Ligue Nationale Contre le Cancer, SIRIC CURAMUS, Centre de recherche Saint Antoine, Paris, France., Raeisi M; Statistical Unit, ARCAD Foundation, Paris, France. Electronic address: morteza.raeisi@fondationarcad.org., Chibaudel B; Department of Medical Oncology, Franco-British Hospital, Fondation Cognacq-Jay, Levallois-Perret, France., Shi Q; Department of Quantitative Health Science, Mayo Clinic, Rochester, USA., Yoshino T; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Zalcberg JR; Monash University School of Public Health and Preventive Medicine and Department of Medical Oncology, Alfred Health, Melbourne, VIC, Australia., Adams R; Cardiff University and Velindre Cancer Centre, Cardiff, United Kingdom., Cremolini C; Department of Translational Research and New Technologies, University of Pisa, Pisa, Italy., Van Cutsem E; Department of Gastrointestinal and Liver Diseases, Digestive Oncology Unit, University Hospitals Leuven and KU Leuven, Leuven, Belgium., Heinemann V; Department of Medical Oncology, LMU Hospital, University of Munich, Munich, Germany., Tabernero J; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), IOB-Quiron, Barcelona, Spain., Punt CJA; University Medical Center Utrecht, Utrecht, the Netherlands., Arnold D; Asklepios Tumorzentrum Hamburg, Asklepios Klinik Altona, Hamburg, Germany., Hurwitz HI; Duke University, Durham, NC, USA., Douillard JY; Medical Oncology Department, Integrated Centers for Oncology Nantes, Nantes, France., Venook AP; Department of Medicine, The University of California San Francisco, San Francisco, CA, USA., Saltz LB; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Maughan TS; University of Liverpool, Liverpool, United Kingdom., Kabbinavar F; Cardiff Oncology, San Diego, USA., Bokemeyer C; Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Grothey A; West Cancer Center, Germantown, TN, USA., Mayer RJ; Dana-Farber Cancer Institute, Boston, MA, USA., Kaplan R; MRC Clinical Trials Unit at UCL, London, UK., Tebbutt NC; Department of Medical Oncology, Olivia Newton-John Cancer, Wellness and Research Centre, Austin Health, Heidelberg, VIC, Australia., Randolph Hecht J; David Geffen School of Medicine at UCLA, University of California at Los Angeles, Los Angeles, USA., Giantonio BJ; Massachusetts General Hospital, Boston, MA, USA., Díaz-Rubio E; Hospital Clínico San Carlos, Prof. Martín Lagos, 28040 Madrid, Spain., Sobrero AF; Department of Medical Oncology, Ospedale San Martino, Genoa, Italy., Peeters M; University Hospital Ghent, Ghent, Belgium., Koopman M; University Medical Center Utrecht, Utrecht, the Netherlands., Goldberg RM; Department of Medicine, West Virginia University Cancer Institute, Morgantown, USA., Andre T; Sorbonne University, Department of Medical Oncology, Hôpital Saint-Antoine, AP-HP, and INSERM UMRS 938, Équipe Instabilité des Microsatellites et Cancer, Équipe Labellisée par la Ligue Nationale Contre le Cancer, SIRIC CURAMUS, Centre de recherche Saint Antoine, Paris, France; ARCAD Foundation, Paris, France., de Gramont A; ARCAD Foundation, Paris, France; Department of Medical Oncology, Franco-British Hospital, Levallois-Perret, France.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Aug; Vol. 207, pp. 114160. Date of Electronic Publication: 2024 Jun 10.
Autor:
Cazeneuve N; Department of Radiology, Hôpital Trousseau, CHRU de Tours, 37044 Tours Cedex 09, France., Bouché O; Department of Hepatogastroenterology, Hôpital Robert Debré, CHU de Reims, avenue Général Koenig, 51092 Reims Cedex, France., Leger J; INSERM CIC 1415, CHRU de Tours, CHRU de Tours, 37044 Tours Cedex 09, France., Borg C; Department of Medical Oncology, Hôpital Jean Minjoz, CHRU de Besançon, 3 Boulevard Alexandre Fleming, 25000 Besançon, France., Labbe-Devilliers C; Department of Radiology, ICO René Gauducheau, 44805 Saint-Herblain, France., Lucidarme O; Department of Radiology, Hôpital Pitié-Salpétrière, APHP, 47, Boulevard de l'Hôpital, 75013 Paris, France., Tasu JP; Department of Radiology, CHU de Poitiers, 2 rue Milétrie, 86021 Poitiers Cedex, France., Manfredi S; Department of Hepatogastroenterology and Digestive Oncology, CHU de Rennes, Hôpital Pontchaillou, 2 rue Henri Le Guilloux, 35033 Rennes Cedex 9, France., Aubé C; Department of Radiology, CHU d'Angers, 4 rue Larrey 49100 Angers, France., Trillaud H; Department of Diagnostic and Interventional Imaging, Hôpital Saint-André, CHU de Bordeaux, 1 rue Jean Burguet, 33000 Bordeaux, France., Manzoni P; Department of Radiology, Hôpital Jean Minjoz, CHRU de Besançon, Hôpital Jean Minjoz, CHRU de Besançon, 3 Boulevard Alexandre Fleming, 25000 Besançon, France., Marcus C; Department of Radiology, Hôpital Robert Debré, CHU de Reims, avenue Général Koenig, 51092 Reims Cedex, France., Terrebonne E; Department of Hepatogastroenterology and Digestive Oncology, Hôpital du Haut Lêvèque, CHU de Bordeaux, avenue Magellan, 33604 Pessac Cedex, France., Douillard JY; Department of Medical Oncology, ICO René Gauducheau, 44805 Saint-Herblain, France., Chautard R; Department of Hepatogastroenterology and Digestive Oncology, Hôpital Trousseau, CHRU de Tours, 37044 Tours Cedex 09, France; UMR INSERM U 1069, Université de Tours, 10 Boulevard Tonnellé, 37000 Tours, France., Lobet S; UMR INSERM U 1069, Université de Tours, 10 Boulevard Tonnellé, 37000 Tours, France., Scotto B; Department of Radiology, Hôpital Trousseau, CHRU de Tours, 37044 Tours Cedex 09, France., Bleuzen A; Department of Radiology, Hôpital Bretonneau, CHRU de Tours, CHRU de Tours, 37044 Tours Cedex 09, France., Lecomte T; Department of Hepatogastroenterology and Digestive Oncology, Hôpital Trousseau, CHRU de Tours, 37044 Tours Cedex 09, France; UMR INSERM U 1069, Université de Tours, 10 Boulevard Tonnellé, 37000 Tours, France. Electronic address: thierry.lecomte@med.univ-tours.fr.
Publikováno v:
Clinics and research in hepatology and gastroenterology [Clin Res Hepatol Gastroenterol] 2024 Aug; Vol. 48 (7), pp. 102380. Date of Electronic Publication: 2024 May 23.
Autor:
Ou FS; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA., Ahn DH; Division of Medical Oncology, Mayo Clinic, Phoenix, AZ 85259, USA., Dixon JG; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA., Grothey A; West Cancer Center, University of Tennessee, Memphis, TN 38104, USA., Lou Y; Vertex Pharmaceuticals, Boston, MA 02210, USA., Kasi PM; Division of Hematology and Oncology, University of Iowa, Iowa City, IA 52242, USA., Hubbard JM; Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA., Van Cutsem E; Department of Gastroenterology/Digestive Oncology, University Hospitals Gasthuisberg Leuven and KU Leuven, 3000 Leuven, Belgium., Saltz LB; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Schmoll HJ; Department of Internal Medicine, Clinic for Internal Medicine IV, Martin-Luther-University Halle/Saale, 06120 Halle, Germany., Goldberg RM; West Virginia University Cancer Institute, West Virginia University, Morgantown, WV 26506, USA., Venook AP; Department of Medicine, The University of California San Francisco, San Francisco, CA 94143, USA., Hoff P; Department of Clinical Oncology, University of Sao Paulo, Sao Paulo 05508-010, Brazil., Douillard JY; Department of Medical Oncology, University of Nantes Medical School, 44035 Nantes, France., Hecht JR; Ronald Reagan UCLA Medical Center, Los Angeles, CA 90095, USA., Hurwitz H; Duke Cancer Institute, Duke University, Durham, NC 27710, USA., Punt CJA; Julius Center, University Medical Centre Utrecht, Utrecht University, 3584 CG Utrecht, The Netherlands., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, 3584 CX Utrecht, The Netherlands., Bokemeyer C; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany., Fuchs CS; Yale Cancer Center, New Haven, CT 06510, USA., Diaz-Rubio E; Department of Oncology, Hospital Clínico San Carlos, 28040 Madrid, Spain., Tebbutt NC; Sydney Medical School, University of Sydney, Sydney, NSW 2050, Australia., Cremolini C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126 Pisa, Italy., Kabbinavar FF; Cardiff Oncology, San Diego, CA 92121, USA., Bekaii-Saab T; Division of Medical Oncology, Mayo Clinic, Phoenix, AZ 85259, USA., Chibaudel B; Department of Medical Oncology, Franco-British Institute, 92300 Levallois-Perret, France., Yoshino T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba 277-8577, Japan., Zalcberg J; School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC 3004, Australia., Adams RA; Centre for Trials Research, Cardiff University, Cardiff CF14 4YS, UK.; Velindre Cancer Center, Velindre NHS Trust, Cardiff CF14 2TL, UK., de Gramont A; Department of Medical Oncology, Franco-British Institute, 92300 Levallois-Perret, France., Shi Q; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Aug 15; Vol. 15 (16). Date of Electronic Publication: 2023 Aug 15.
Autor:
Fukuoka M; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Yano S; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Giaccone G; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Tamura T; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Nakagawa K; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Douillard JY; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Nishiwaki Y; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Vansteenkiste J; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Kudoh S; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Rischin D; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Eek R; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Horai T; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Noda K; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Takata I; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Smit E; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Averbuch S; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Macleod A; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Feyereislova A; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Dong RP; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain., Baselga J; From the Kinki University School of Medicine, Osaka City University School of Medicine, and AstraZeneca, Osaka, Tokushima University School of Medicine, Tokushima, National Cancer Center, Central Hospital, and Japanese Foundation for Cancer Research, Tokyo, National Cancer Center, East Hospital, Chiba, Kanagawa Cancer Center, Yokohama, and National Shikoku Cancer Center, Matsuyama, Japan; C.R.L.C.C. Rene Gauducheau, Saint-Herblain, France; University Hospital Gasthuisberg, Leuven, Belgium; Centre for Developmental Cancer Therapeutics, Melbourne, Australia; Mary Potter Oncology Centre, Pretoria, South Africa; Academic Hospital Free University, Amsterdam, the Netherlands; AstraZeneca, Wilmington, DE; AstraZeneca, Alderley Park, United Kingdom; and Vall d'Hebron University Hospital, Barcelona, Spain.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Feb 20; Vol. 41 (6), pp. 1162-1171.
Autor:
Mikhail Lette MN; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Paez D; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Shulman LN; The Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA., Guckenberger M; University Hospital Zurich: UniversitatsSpital, Zurich, Switzerland., Douillard JY; European Society for Medical Oncology, Lugano, Switzerland., Oyen WJG; European Association of Nuclear Medicine, Vienna, Austria., Giammarile F; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Rangarajan V; Tata Memorial Centre, Mumbai, Maharashtra, India., Ginsberg M; Memorial Sloan Kettering Cancer Center, New York, NY., Pellet O; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Liao Z; MD Anderson Cancer Center, Houston, TX., Abdel Wahab M; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria.
Publikováno v:
JCO global oncology [JCO Glob Oncol] 2022 May; Vol. 8, pp. e2100100.
Autor:
Papamichael D; Bank of Cyprus Oncology Centre, Nicosia, Cyprus. Electronic address: demetris.papamichael@bococ.org.cy., Lopes GS; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Olswold CL; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Douillard JY; University of Nantes, And Integrated Centers of Oncology ICO René Gauducheau Cancer, Nantes, France., Adams RA; Cardiff University and Velindre Cancer Centre, Cardiff, UK., Maughan TS; School of Medicine, Cardiff University, Cardiff, UK., Van Cutsem E; Digestive Oncology, University Hospitals Gasthuisberg Leuven and University of Leuven, Leuven, Belgium., Venook AP; Helen Diller Family Comprehensive Cancer Center, USA., Lenz HJ; Department of Gastrointestinal Onocology, Keck School of Medicine at USC, Los Angeles, CA, USA., Heinemann V; Department of Medicine III, University Hospital, Ludwig Maximilian University, Munich, Germany., Kaplan R; Medical Research Council Clinical Trials Unit, University College London, London, UK., Bokemeyer C; Department of Oncology, Haematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Chibaudel B; Franco-British Institute, Levallois-Perret, France., Grothey A; West Cancer Center and Research Institute, OneOncology, Germantown, TN, USA., Yoshino T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Japan., Zalcberg J; School of Public Health and Preventative Medicine, Monash University, Melbourne, Australia., De Gramont A; Franco-British Institute, Levallois-Perret, France., Shi Q; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Mar; Vol. 163, pp. 1-15. Date of Electronic Publication: 2022 Jan 13.
Autor:
Latino NJ; ESMO Head Office, Lugano, Switzerland. Electronic address: nicola.latino@esmo.org., Galotti M; ESMO Head Office, Lugano, Switzerland., Cherny NI; Cancer Pain and Palliative Medicine Service, Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel., de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: https://twitter.com/VriesElisabeth., Douillard JY; Medical Oncology, Integrated Centers for Oncology (ICO), Nantes, France., Kaidarova D; Kazakh Institute of Oncology and Radiology, Kazakh National Medical University named after S.D. Asfendiyarov, Kazakh Cancer Society, Almaty, The Republic of Kazakhstan., Ilbawi A; Department of Noncommunicable Diseases, World Health Organization, Geneva, Switzerland.
Publikováno v:
ESMO open [ESMO Open] 2022 Feb; Vol. 7 (1), pp. 100362. Date of Electronic Publication: 2022 Jan 31.
Autor:
Cohen R; Department of Health Science Research, Mayo Clinic, Rochester, MN, USA.; Department of Medical Oncology, Sorbonne University, Saint-Antoine Hospital, Paris, France., Liu H; Department of Health Science Research, Mayo Clinic, Rochester, MN, USA., Fiskum J; Department of Health Science Research, Mayo Clinic, Rochester, MN, USA., Adams R; Cardiff University and Velindre Cancer Centre, Cardiff, UK., Chibaudel B; Department of Medical Oncology, Franco-British Institute, Levallois-Perret, France., Maughan TS; Cancer Research UK and the Medical Research Council Oxford Institute for Radiation Oncology, Oxford, UK., Van Cutsem E; Digestive Oncology, University Hospitals Gasthuisberg Leuven and University of Leuven, Belgium., Venook A; Department of Medicine, The University of California San Francisco, San Francisco, CA, USA., Douillard JY; University of Nantes Medical School Nantes, France., Heinemann V; Department of Medical Oncology and Comprehensive Cancer Center, University of Munich, Munich, Germany., Ja Punt C; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands., Falcone A; Department of Oncology, University of Pisa, Italy., Bokemeyer C; Department of Oncology, Haematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Kaplan R; Medical Research Council Clinical Trials Unit, University College London, London, UK., Lenz HJ; Department of Gastrointestinal Oncology, Keck School of Medicine at USC, Los Angeles, CA, USA., Koopman M; Department of Medical Oncology, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands., Yoshino T; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan., Zalcberg J; Monash University, Melbourne, Australia., Grothey A; West Cancer Center, Germantown, TN, USA., de Gramont A; Department of Medical Oncology, Franco-British Institute, Levallois-Perret, France., Shi Q; Department of Health Science Research, Mayo Clinic, Rochester, MN, USA., André T; Department of Medical Oncology, Sorbonne University, Saint-Antoine Hospital, Paris, France.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Oct 01; Vol. 113 (10), pp. 1386-1395.